Literature DB >> 35834035

Mitochondrial oxidative phosphorylation became functional under aglycemic hypoxia conditions in A549 cells.

Yüksel Öğünç Keçeci1, Zerrin İncesu2.   

Abstract

BACKGROUND: Normal cells produce energy (ATP) through mitochondrial oxidative phosphorylation in the presence of oxygen. However, many of the cancer cells produce energy with accelerated glycolysis and perform lactic acid production even under normoxic conditions called "The Warburg Effect". In this study, human lung carcinoma cells (A549) were incubated in either a normoxic or hypoxic environment containing 5 mM glucose (Glc 5), 25 mM glucose (Glc 25), or 10 mM galactose (OXPHOS/aglycemic), and then the bioenergetic pathway was anaylsed. METHODS AND
RESULTS: HIF-1α stabilization of A549 cells with different metabolic conditions in normoxia and hypoxia (1% O2) was determined using the western blot method. After that, L-lactic acid analysis, p-PDH/PDH expression ratio, ATP analysis, and citrate synthase activity experiments were also performed. It was determined that HIF-1α stabilization reached the maximum level at the 4 h. It has been found that glycolytic cells produce approximately five times more lactate than OXPHOS cells under both normoxia and hypoxia conditions and also have a higher p-PDH/PDH ratio. It has been determined that citrate synthase activity in hypoxia of all metabolic conditions is lower than normoxia. It has been determined that Glc 5 and Glc 25 cells have more ATP production under normoxia than Glc 5 and Glc 25 cells in hypoxia. OXPHOS cells have showed more ATP production in hypoxia.
CONCLUSION: It has been determined that oxidative phosphorylation became functional in a hypoxic aglycemic environment despite the metabolic programming regulated by HIF-1α. This data is important in determining targets for therapeutic intervention.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  A549 cells; Glucose metabolism; Oxidative phosphorylation; Tumor hypoxia; Warburg effect

Mesh:

Substances:

Year:  2022        PMID: 35834035     DOI: 10.1007/s11033-022-07400-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  36 in total

Review 1.  Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1.

Authors:  G L Semenza
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

2.  The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.

Authors:  K L Talks; H Turley; K C Gatter; P H Maxwell; C W Pugh; P J Ratcliffe; A L Harris
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 3.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

4.  The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha.

Authors:  A Sodhi; S Montaner; V Patel; M Zohar; C Bais; E A Mesri; J S Gutkind
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

5.  Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells.

Authors:  H Tian; S L McKnight; D W Russell
Journal:  Genes Dev       Date:  1997-01-01       Impact factor: 11.361

6.  Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway.

Authors:  Daniel P Stiehl; Wolfgang Jelkmann; Roland H Wenger; Thomas Hellwig-Bürgel
Journal:  FEBS Lett       Date:  2002-02-13       Impact factor: 4.124

7.  Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer.

Authors:  Lili Liu; Xiaoxuan Ning; Li Sun; Hongbo Zhang; Yongquan Shi; Changcun Guo; Shuang Han; Jie Liu; Shiren Sun; Zheyi Han; Kaichun Wu; Daiming Fan
Journal:  Cancer Sci       Date:  2007-10-22       Impact factor: 6.716

8.  Proteomics-based identification of two novel direct targets of hypoxia-inducible factor-1 and their potential roles in migration/invasion of cancer cells.

Authors:  Shi-Hua Liao; Xu-Yun Zhao; Yu-Hui Han; Jing Zhang; Li-Shun Wang; Li Xia; Ke-Wen Zhao; Ying Zheng; Meng Guo; Guo-Qiang Chen
Journal:  Proteomics       Date:  2009-08       Impact factor: 3.984

9.  Tumor metabolism: cancer cells give and take lactate.

Authors:  Gregg L Semenza
Journal:  J Clin Invest       Date:  2008-11-20       Impact factor: 14.808

10.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

Authors:  H Zhong; A M De Marzo; E Laughner; M Lim; D A Hilton; D Zagzag; P Buechler; W B Isaacs; G L Semenza; J W Simons
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.